Advertisement
Screener

NovoCure Limited (NVCR) Operating Lease Liability

NovoCure Limited Operating Lease Liability

NovoCure Limited (NVCR) had Operating Lease Liability of $53.31 million as of 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Balance Sheet › Liabilities

us-gaap:OperatingLeaseLiability · last filed 2026-02-26

  • 2025-12-31: Operating Lease, Liability $53.31M.
  • 2024-12-31: Operating Lease, Liability $27.88M.
  • 2023-12-31: Operating Lease, Liability $35.64M.
  • 2022-12-31: Operating Lease, Liability $24.57M.
Period endOperating Lease, Liability
2025-12-31$53.31M
10-K · filed 2026-02-26
2024-12-31$27.88M
10-K · filed 2025-02-27
2023-12-31$35.64M
10-K · filed 2024-02-22
2022-12-31$24.57M
10-K · filed 2023-02-23
2021-12-31$19.68M
10-K · filed 2022-02-24
2020-12-31$20.78M
10-K · filed 2021-02-25
2019-12-31$18.77M
10-K · filed 2020-02-27
2019-09-30$15.62M
10-Q · filed 2019-10-31
2019-06-30$15.53M
10-Q · filed 2019-07-25
2019-03-31$14.78M
10-Q · filed 2019-05-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77